To evaluate the effectiveness of total parathyroidectomy (PTX) with autotransplantation in the treatment of secondary hyperparathyroidism (HPT), and to assess recurrence rate of HPT in this peritoneal dialysis (PD) population.
Design
A retrospective study in a single home PD unit.
Patients
Between 1994 and 1998, 19 of 574 patients on PD underwent PTX for treatment of secondary HPT.
Main Outcome Measures
Clinical and biochemical improvement, recurrence of HPT, improvement in anemia post-PTX.
Results
Nineteen (3.3%) patients required PTX between 1994 and 1998. These 5 men and 14 women ranged in age from 22 to 66 years; they had been on maintenance PD pre-PTX for 47.5 ± 38.1 months, and were followed for 26.1 ± 15.5 months post-PTX. Sixteen patients had temporary hypocalcemia that was managed by oral (n = 10) or intravenous (n = 6) calcium supplements and calcitriol, while 3 patients had severe “hungry bone” syndrome postoperatively. One patient had recurrent laryngeal nerve palsy post-PTX. Bone pain disappeared in all 12 patients. Pruritus improved in 12/13 patients; fatigue improved in 15/16 patients. Comparison showed significant differences between hemoglobin and hematocrit values 1 month pre-PTX and 12 months post-PTX (p < 0.05). Parathyroid hormone (PTH) level in 15 (79%) patients returned to normal (≤€7.6 pmol/L) during the first month post-PTX. In 5/12 (42%) patients, PTH level was ≤ 7.6 pmol/L 2 years post-PTX, while in 2/12 (17%), PTH was > 22.8 pmol/L (three times normal) 2 years post-PTX, and 3/5 (60%) patients had a PTH > 22.8 pmol/L 3 years post-PTX.
Conclusions
Total PTX with autotransplantation is associated with a tendency for recurrence of HPT. Our findings suggest that total PTX with autotransplantation may be an ineffective procedure in controlling HPT over the long term.
FelsenfeldA.J.Considerations for the treatment of secondary hyperparathyroidism in renal failure.J Am Soc Nephrol1997; 8: 993–1004.
2.
CannellaG., and MessaP.Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease.Int J Artif Organs1999; 22: 1–7.
3.
GonzalezE.A., and MartinK.J.Renal osteodystrophy: Pathogenesis and management.Nephrol Dial Transplant1995; 10(Suppl 3): 13–21.
4.
FelsenfeldA.J., and RodriguezM.Phosphorus, regulation of plasma calcium, and secondary hyperparathyroidism: A hypothesis to integrate a historical and modern perspective.J Am Soc Nephrol1999; 10: 878–90.
5.
LlachF., and YuddM.Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure.Am J Kidney Dis1998; 32(Suppl 2): S3–12.
6.
FournierA., OprisiuR., HottelartC., YverneauP.H., GhazaliA., AtikA.Renal osteodystrophy in dialysis patients: Diagnosis and treatment.Artif Organs1998; 22: 530–57.
FassbinderW., BrunnerF.P., BryngerH., EhrichJ.H., GeerlingsW., RaineA.E.Combined report on regular dialysis and transplantation in Europe.Nephrol Dial Transplant1991; 6(Suppl 1): 5–35.
9.
StanburyS.W., LumbG.A., NicholsonW.F.Elective sub-total parathyroidectomy for renal hyperparathyroidism.Lancet1960; 1: 793–9.
10.
KorzetsZ., MagenH., KrausL., BernheimJ., BernheimJ.Total parathyroidectomy with autotransplantation in haemodialysed patients with secondary hyperparathyroidism—should it be abandoned?Nephrol Dial Transplant1987; 2: 341–6.
11.
KayeM., D'AmourP., HendersonJ.Elective total parathyroidectomy without autotransplant in end-stage renal disease.Kidney Int1989; 35: 1390–9.
12.
HigginsR.M., RichardsonA.J., RatcliffeP.J., WoodsC.G., OliverD.O., MorrisP.J.Total parathyroidectomy alone or with autograft for renal hyperparathyroidism?Q J Med1991; 79: 323–32.
13.
PunchJ.D., ThompsonN.W., MerionR.M.Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients. A 25-year single-center experience.Arch Surg1995; 130: 538–42; Discussion: 542–3.
14.
ZaracaF., MazzaferroS., CatarciM., SaputelliA., AloP., CarboniM.Prospective evaluation of total parathyroidectomy and autotransplantation for the treatment of secondary hyperparathyroidism.Arch Surg1999; 134: 68–72.
15.
StrackeS., JehleP.M., SturmD., SchoenbergM.H., WidmaierU., BegerH.G., KellerF.Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure.Am J Kidney Dis1999; 33: 304–11.
16.
HowardR.J., and PfaffW.W.Parathyroidectomy in patients with chronic renal failure.Am J Surg1998; 175: 302–4.
17.
RothmundM., WagnerP.K., ScharkC.Subtotal parathyroidectomy versus total parathyroidectomy and auto-transplantation in secondary hyperparathyroidism: A randomized trial.World J Surg1991; 15: 745–50.
18.
HenryJ-FR, DenizotA., AudiffretJ., FranceG.Results of reoperations for persistent or recurrent secondary hyperparathyroidism in hemodialysis patients.World J Surg1990; 14: 303–7.
19.
NeonakisE., WheelerM.H., KrishnanH., ColesG.A., DaviesF., WoodheadJ.S.Results of surgical treatment of renal hyperparathyroidism.Arch Surg1995; 130: 643–8.
20.
HamplH., SteinmullerT., StabellU., KilgenbergH.J., SchnoyN., NeuhausP.Recurrent hyperparathyroidism after total parathyroidectomy and autotransplantation in patients with long-term hemodialysis.Miner Electrolyte Metab1991; 17: 256–60.
21.
KayeM., RosenthallL., HillR.O., TabahR.J.Long-term outcome following total parathyroidectomy in patients with end-stage renal disease.Clin Nephrol1993; 39: 192–7.
22.
LjuticD., CameronJ.S., OggC.S., TurnerC., HicksJ.A., OwenW.J.Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure.QJM1994; 87: 685–92.
23.
TominagaY., KoharaS., NamiiY., NagasakaT., HabaT., UchidaK.Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism.World J Surg1996; 20: 744–50.
24.
MartinL.N.C., KayathM.J., VieiraJ.G.H., Nose–AlbertiV.Parathyroid glands in uraemic patients with refractory hyperparathyroidism: Histopathology and p53 protein expression analysis.Histopathology1998; 33: 46–51.
25.
WellsS.A., GunnellsJ.C., ShelburneJ.D.Transplantation of the parathyroid glands in man: Clinical indications and results.Surgery1975; 78: 34–44.
26.
LlachF.Parathyroidectomy in chronic renal failure: Indications, surgical approach and the use of calcitriol.Kidney Int1990; 38(Suppl 29): S62–8.
27.
TorresA., LorenzoV., HernandezD., RodriguezJ.C., ConcepcionM.T., RodriguezA.Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH.Kidney Int1995; 47: 1434–42.
28.
SkinnerK.A., and ZuckerbraunL.Recurrent secondary hyperparathyroidism.Arch Surg1996; 131: 724–7.
29.
CruzD.N., and PerazellaM.A.Biochemical aberrations in a dialysis patient following parathyroidectomy.Am J Kidney Dis1997; 29: 759–62.
30.
CutterR.E.Lipid disorders in renal disease: Prevalence, pathogenesis and diagnosis.Dial Transplant1988; 17: 533–6.
31.
LacourB., BasileC., DruekeT., Funck–BrentanoJ.L.Parathyroid function and lipid metabolism in the rat.Miner Electrolyte Metab1982; 7: 157–65.
HeuckC.C., LierschM., RitzE., StegmeierK., WirthA., MehlsO.Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat.Kidney Int1978; 14: 142–50.
34.
CantinM.Kidney, parathyroid, and lipemia.Lab Invest1965; 14: 1691–7.
35.
KlinM., SmogorzewskiM., NiZ., ZhangG., MassryS.G.Abnormalities in hepatic lipase in chronic renal failure: Role of excess parathyroid hormone.J Clin Invest1996; 97: 2167–73.
36.
VaziriN.D., and LiangK.Role of secondary hyperparathyroidism in the pathogenesis of depressed lipoprotein lipase expression in chronic renal failure.Am J Physiol (Renal Physiol)1997; 273: F925–30.
37.
VaziriN.D., and LiangK.Down-regulation of tissue lipoprotein lipase in experimental chronic renal failure.Kidney Int1996; 50: 1928–35.
38.
BagdadeJ., YeeE., PykalistoO.J.Parathyroid hormone and triglyceride transport: Effect on triglyceride secretion rates and adipose tissue lipoprotein lipase in the rat.Horm Metab Res1978; 10: 443–6.
39.
BasileC., DriiekeT., LacourB.Has parathyroid hormone any influence on lipid metabolism in chronic renal failure?Nephrol Dial Transplant1995; 10: 1942–3.
40.
NavarroJ.F., TeruelJ.L., LasuncionM.A., Mora– FernandezC., OrtunoJ.Relationship between serum parathyroid hormone levels and lipid profile in hemodialysis patients. Evolution of lipid parameters after parathyroidectomy.Clin Nephrol1998; 49: 303–7.
41.
MeytesD., BoginE., MaA., DukesP., MassryS.Effect of parathyroid hormone in erythropoiesis.J Clin Invest1981; 67: 1263–9.
42.
McGonigleR.J.S., WallinJ.D., HusserlF., DeftosL.J., RiceJ.C., O'NeilW.J.Potential role of parathyroid hormone as an inhibitor of erythropoietin in the anaemia of renal failure.J Lab Clin Med1984; 104: 1016–26.
43.
GoicoecheaM., VazquezM.I., RuizM.A., Gomez– CampderaF., Perez–GarciaR., ValderrabanoF.Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.Nephron1998; 78: 23–7.
44.
CassidyM.J.D., EllisH.A., DewarJ.The anemia of chronic renal failure: Is there an association with secondary hyperparathyroidism?Kidney Int1984; 26: 897–9.
45.
PotasmanI., and BetterO.S.The role of secondary hyperparathyroidism in the anemia of chronic renal failure.Nephron1983; 33: 229–31.
